Tanner Pharma Group delivers on “last mile” in global health

The Max Foundation (“Max”), an international health organization dedicated to serving cancer patients, and Tanner Pharma Group (“Tanner”), a global pharma services company specializing in access to critical medication, are committed partners in bringing thousands of patients around the globe daily access to cancer treatment. Within The Max Foundation’s patient-centered model, Max Access Solutions (MAS), Tanner plays a critical role by leading quality, regulatory and logistics to ensure donated oncology products get to the right patient in the right place at the right time. MAS programs currently deliver 1,000,000 daily doses per Quarter.

Tanner Pharma Group delivers on “last mile” in global health

Among the dozens of countries The Max Foundation supports, many are located in Africa. To raise awareness and funds for increased treatment access on the continent, Max has created a 2018 campaign known as the Max Global Experience: Uganda.

This campaign is focused on the proverbial “last mile,” which refers to the unseen efforts of patients and caregivers to make treatment truly accessible. All too often, patients must travel great distances to attend medical appointments and receive their medication. Max works to bridge these gaps by broadening its geographic reach, working with local patient groups, advocating to governments, and partnering with distribution experts like Tanner. Tanner has proudly offered to be the title sponsor for the Max Global Experience: Uganda and their parent company, Bourne Partners, will match up to $10,000 in funds raised.

As we work to find solutions for patients in need, we feel fortunate to partner with a trusted Managed Access Program provider like Tanner Pharma Group. We are strongly aligned in our values around the importance of access to cancer treatment for people around the world. As a result, we have forged a successful partnership in our Max Access Solution model which provides life-saving medication to patients in more than 70 countries. We look forward to growing our programs with Tanner and improving the lives of more cancer patients in under-resourced countries."

Pat Garcia-Gonzalez, CEO and co-founder of The Max Foundation

We are proud of our affiliation with The Max Foundation and the support we provide for their innovative, globally recognized programs. Working with Pat and her team is deeply rewarding. Their hard work has led to monumental impact at the patient level."

Banks Bourne, Founder & Chairman of Tanner Pharma Group and CEO of Bourne Partners

In 2017, Mr. Bourne attended another Max Global Experience, this time climbing Mt. Kinabalu in Malaysia. Banks recalls, “Seeing their work in Asia last summer and looking ahead to the upcoming trip to Africa has been inspirational and makes Tanner’s mission even more meaningful.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tanner Pharma Group. (2019, August 22). Tanner Pharma Group delivers on “last mile” in global health. News-Medical. Retrieved on November 04, 2024 from https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-delivers-on-last-mile-in-global-health.aspx.

  • MLA

    Tanner Pharma Group. "Tanner Pharma Group delivers on “last mile” in global health". News-Medical. 04 November 2024. <https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-delivers-on-last-mile-in-global-health.aspx>.

  • Chicago

    Tanner Pharma Group. "Tanner Pharma Group delivers on “last mile” in global health". News-Medical. https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-delivers-on-last-mile-in-global-health.aspx. (accessed November 04, 2024).

  • Harvard

    Tanner Pharma Group. 2019. Tanner Pharma Group delivers on “last mile” in global health. News-Medical, viewed 04 November 2024, https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-delivers-on-last-mile-in-global-health.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tanner Pharma Group signs distribution agreement with Nephcentric LLC